INDIVIDUAL ARTICLE: NECOM 5: Algorithm for the Treatment and Supportive Management of Targeted Therapy-Related Cutaneous Adverse Events.
Targeted therapy-related cAEs may negatively affect cancer patients and survivors. The NECOM panel provides a practical algorithm for preventing and managing TTcAEs to improve cancer patient outcomes and quality of life. J Drugs Dermatol. 2025;24:3(Suppl 2):s3-10.
Authors
- Anneke Andriessen (ORCID: https://orcid.org/0000-0001-5930-4162)
- Charles W Lynde (ORCID: https://orcid.org/0000-0001-9163-5463)
- Peter Bjerring (ORCID: https://orcid.org/0000-0002-3031-1390)
- Gabriela Lladó Grove (ORCID: https://orcid.org/0000-0002-6954-4458)
- Ada Girnita (ORCID: https://orcid.org/0000-0001-9541-4772)
- Andreas Stensvold (ORCID: https://orcid.org/0000-0002-2675-5351)
- Samsa Kauppi
Institutions
- Copenhagen University Hospital (DK)
- Aalborg University (DK)
Publication Details
- Journal
- PubMed
- Published
- 2025-03-01
- DOI
- https://doi.org/10.36849/jdd.88541
- Primary Topic
- Chemotherapy-related skin toxicity
- Type
- article